Searched for
PHARMACEUTICAL INTELLECTUAL PROPERTY
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...
- Quote of the day by Tom Gayner: "Equities are congealed intellectual capital, and that is what I want"Investor Tom Gayner views stocks as ownership in businesses built on human ingenuity. He emphasizes that a company's value stems from its i...
- Trump administration proposes 25% tariff to punish Brazil over trade practicesThe United States is proposing a 25% tariff on many imports from Brazil. This action follows an investigation into unfair trade practices. ...
- India, Oman trade pact to come into force from June 1; Check what's insideIndia and Oman's Comprehensive Economic Partnership Agreement, CEPA, begins on June 1. This pact offers Indian exports 100% duty-free acces...
- Reddy Pharma loses 'name' in Delhi HC rulingThe Delhi High Court has ruled against Reddy Pharmaceuticals. The court upheld a decision to remove 'Reddy' from the company's name. Reddy ...
- India, Canada to hold next round of FTA talks in Ottawa in JulyIndia and Canada will hold the next round of free trade agreement negotiations in Ottawa in July. Both nations are committed to a balanced ...
- India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRIIndia is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual prop...
- US raises concerns at India’s duties on IP-intensive goods, source code, AI working paperThe US has voiced concerns over India's high customs duties on IP-intensive products and its proposed mandatory blanket license for AI deve...
- India’s real estate will meet the reality of agentic AIIndia’s IT slowdown, driven by AI-driven automation and shrinking outsourcing demand, is beginning to hit real estate, mortgages, and emplo...
- IP waiver will not lead to increased production of COVID-19 vaccines: OPPIA proposal moved by India and South Africa before the World Trade Organisation (WTO) to temporarily suspend trade-related aspects of intell...
- Medical companies seek G-20 protection for patentsThe warning comes in a report prepared for G-20 leaders by representatives of health and life-sciences companies including Novartis AG, San...
- Food & drinks, pharma to be part of India-UK pact: Jayant Krishna, CEO, UKIBCKrishna also said a trade deal between the UK and EU could be a prelude to a pact between India and the UK. Last month, India and the UK af...
- US Trade Representative nominee promises aggressive posture on India's IP regimeLighthizer said, "I think we need a policy that is as aggressive as we can have. There are a whole lot of areas where we are at risk in int...
- Rising spectre of cybercrime in the pharmaceutical sectorPharma sector is a prime target for cyber attackers as it hosts prized intellectual property that is of immense value to criminals and comp...
- In desi Viagra market, companies fight over namesSettling a trademark dispute between two major desi viagra players on Wednesday, the IPAB disallowed them from using two trademarks.
- Orchid Chemicals, Allecra in pact to develop antibioticsDrug firm Orchid Chemicals & Pharmaceuticals said it has inked a strategic pact with Europe-based Allecra Therapeutics to develop novel ant...
- Glenmark gets licence for chronic pain treatment from LLGGlenmark Pharmaceuticals said it has received exclusive license to the entire IP of Lay Line Genomics for a specific process for treating c...
- PMO circulates note on IPR tweaks for drug MNCsThe government is considering a set of proposals by global drugmakers that seeks certain changes in the country’s intellectual property rig...
Load More
